1. A phase II study of AT9283, an aurora kinase inhibitor, in patients with relapsed or refractory multiple myeloma: NCIC clinical trials group IND.191. Issue 6 (2nd June 2016) Authors: Hay, Annette E.; Murugesan, Alli; DiPasquale, Ashley M.; Kouroukis, Tom; Sandhu, Irwindeep; Kukreti, Vishal; Bahlis, Nizar J.; Lategan, Johan; Reece, Donna E.; Lyons, John F.; Sederias, Joana; Xu, Hao; Powers, Jean; Seymour, Lesley K.; Reiman, Tony Journal: Leukemia & lymphoma Issue: Volume 57:Issue 6(2016:Jun.) Page Start: 1463 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Absolute lymphocyte count as predictor of overall survival for patients with multiple myeloma treated with single autologous stem cell transplant. Issue 9 (2nd September 2015) Authors: Jimenez-Zepeda, Victor H.; Reece, Donna E.; Trudel, Suzanne; Chen, Christine; Franke, Norman; Winter, Andrew; Tiedemann, Rodger; Kukreti, Vishal Journal: Leukemia & lymphoma Issue: Volume 56:Issue 9(2015:Sep.) Page Start: 2668 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. An open-label, pharmacokinetic study of lenalidomide and dexamethasone therapy in previously untreated multiple myeloma (MM) patients with various degrees of renal impairment – validation of official dosing guidelines. Issue 8 (2nd July 2020) Authors: Chen, Christine I.; Cao, Yanshuo; Trudel, Suzanne; Reece, Donna E.; Kukreti, Vishal; Tiedemann, Rodger; Prica, Anca; Paul, Harminder; Le, Lisa W.; Levina, Olga; Kakar, Sumeet; Lau, Anthea; Chen, Hongzhuan; Chen, Eric Journal: Leukemia & lymphoma Issue: Volume 61:Issue 8(2020) Page Start: 1860 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Autologous stem cell transplant is an effective therapy for carefully selected patients with AL amyloidosis: experience of a single institution. (25th November 2013) Authors: Jimenez‐Zepeda, Victor H.; Franke, Norman; Reece, Donna E.; Trudel, Suzanne; Chen, Christine; Delgado, Diego H.; Winter, Andrew; Mikhael, Joseph R.; Tiedemann, Rodger; Kukreti, Vishal Journal: British journal of haematology Issue: Volume 164:Number 5(2014:Mar.) Page Start: 722 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Central nervous system involvement with multiple myeloma: long term survival can be achieved with radiation, intrathecal chemotherapy, and immunomodulatory agents. (15th June 2013) Authors: Chen, Christine I.; Masih‐Khan, Esther; Jiang, Haiyan; Rabea, Ahmed; Cserti‐Gazdewich, Christine; Jimenez‐Zepeda, Victor H.; Chu, Chia‐Min; Kukreti, Vishal; Trudel, Suzanne; Tiedemann, Rodger; Tsang, Richard; Reece, Donna E. Journal: British journal of haematology Issue: Volume 162:Number 4(2013:Aug.) Page Start: 483 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Efficacy of thalidomide‐based therapy following lenalidomide plus dexamethasone in patients with relapsed/refractory multiple myeloma. Issue 4 (12th March 2013) Authors: Kukreti, Vishal; Masih‐Khan, Esther; Young, Trieu; Chu, Chia‐Min; Jiang, Haiyun; Trudel, Suzanne; Chen, Christine; Jimenez‐Zepeda, Victor; Reece, Donna E. Journal: American journal of hematology Issue: Volume 88:Issue 4(2013:Apr.) Page Start: 337 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Intermittent granulocyte colony-stimulating factor for neutropenia management in patients with relapsed or refractory multiple myeloma treated with lenalidomide plus dexamethasone. Issue 2 (February 2015) Authors: Sun, Haowei (Linda); Atenafu, Eshetu G.; Yeboah, Elizabeth; Reece, Donna E.; Trudel, Suzanne; Kukreti, Vishal; Masih-Khan, Esther; Winter, Andrew; Chen, Christine Journal: Leukemia & lymphoma Issue: Volume 56:Issue 2(2015:Feb.) Page Start: 407 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Lenalidomide (Revlimid), bortezomib (Velcade) and dexamethasone for the treatment of secondary plasma cell leukemia. Issue 1 (January 2015) Authors: Jimenez-Zepeda, Victor H.; Reece, Donna E.; Trudel, Suzanne; Chen, Christine; Tiedemann, Rodger; Kukreti, Vishal Journal: Leukemia & lymphoma Issue: Volume 56:Issue 1(2015:Jan.) Page Start: 232 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Long‐term survival with cyclophosphamide, bortezomib and dexamethasone induction therapy in patients with newly diagnosed multiple myeloma. (30th June 2014) Authors: Reeder, Craig B.; Reece, Donna E.; Kukreti, Vishal; Mikhael, Joseph R.; Chen, Christine; Trudel, Suzanne; Laumann, Kristina; Vohra, Harjot; Fonseca, Rafael; Bergsagel, P. Leif; Leis, Jose F.; Tiedemann, Rodger; Stewart, A. Keith Journal: British journal of haematology Issue: Volume 167:Number 4(2014:Nov.) Page Start: 563 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Oligoclonal and monoclonal bands after single autologous stem cell transplant in patients with multiple myeloma: impact on overall survival and progression-free survival. Issue 10 (October 2014) Authors: Jimenez-Zepeda, Victor H.; Reece, Donna E.; Trudel, Suzanne; Franke, Norman; Winter, Andrew; Chen, Christine; Tiedemann, Rodger; Kukreti, Vishal Journal: Leukemia & lymphoma Issue: Volume 55:Issue 10(2014:Oct.) Page Start: 2284 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗